A Single-Centre Prospective Phase 0 Translational Study for Predicting Response of High Grade Serous Ovarian Cancers to Paclitaxel Chemotherapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Ovarian cancer
- Focus Biomarker; Pharmacodynamics
- 30 Jan 2013 New trial record
- 17 Jan 2013 Biomarkers information updated